12 analysts have expressed a variety of opinions on BioNTech (NASDAQ:BNTX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 10 | 0 | 1 | 1 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 1 | 1 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 6 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $107.33, a high estimate of $113.00, and a low estimate of $85.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.23%.
Interpreting Analyst Ratings: A Closer Look
An in-depth...
Login or create a forever free account to read this news
Sign up/Log in